Xilio Therapeutics, Inc. (XLO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Xilio Therapeutics, Inc. (XLO) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

XLO Cash Flow Statement

Xilio Therapeutics, Inc. (XLO) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-18.76M	-22.34M	-2M	-17.5M	-14.48M	28.98M	-14.16M	-13.67M	19.95M	-10.5M	-13.43M	-13.37M	-16.57M	-25.25M	-18.22M	-19.91M	-16.76M	-20.84M	-17.16M	-20.72M
Operating CF Margin %	-100.37%	-176.65%	-14.6%	-91.76%	-179.08%	989.01%	-821.17%	-604.15%	846.54%	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-29.6%	-177.1%	85.89%	-27.96%	-172.56%	375.93%	-5.44%	-2.27%	220.39%	58.41%	26.32%	32.85%	1.09%	-21.19%	-6.18%	3.91%	16.79%	8.35%	-35.08%	-
Net Income	-6.37M	-9.53M	10.36M	-16.29M	-15.84M	-13.27M	-13.09M	-14.02M	-13.93M	-17.2M	-17.66M	-16.75M	-19.36M	-22.65M	-22.47M	-19.79M	-24.61M	-21.35M	-19.7M	-16.25M
Depreciation & Amortization	331K	344K	323K	340K	381K	497K	375K	381K	445K	443K	449K	460K	492K	499K	489K	473K	445K	440K	394K	382K
Stock-Based Compensation	1.6M	2.21M	2.93M	1.12M	1.35M	1.53M	1.52M	1.57M	1.51M	1.83M	0	1.86M	1.8M	1.79M	1.81M	1.87M	2.71M	2.03M	2.07M	1.09M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	5.62M	-3.3M	-21.27M	12.02M	2.33M	0	2K	34.74M	-1.85M	0	1.95M	24K	89K	31K	59K	59K	53K	53K	56K	198K
Working Capital Changes	-19.94M	-12.07M	5.66M	-14.69M	-2.7M	40.21M	-2.96M	-36.35M	33.77M	4.42M	1.83M	1.03M	400K	-4.92M	1.88M	-2.52M	4.65M	-2M	18K	-6.14M
Change in Receivables	-1M	5M	12.5M	-17.5M	0	0	0	0	30M	-30M	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.26M	-1.68M	428K	0	2.11M	-590K	1.6M	-281K	0	-305K	-438K	542K	-809K	-1.36M	1.46M	245K	-397K	-820K	-1.19M	-3.55M
Cash from Investing	-19K	-556K	-95K	0	-401K	-22K	-6K	-9K	-21K	0	0	0	-316K	-170K	-509K	-333K	-771K	-254K	-378K	-114K
Capital Expenditures	-19K	-556K	-95K	0	-401K	-22K	-6K	-9K	-21K	0	0	0	-316K	-170K	-509K	-333K	-771K	-254K	-378K	-114K
CapEx % of Revenue	0.1%	4.4%	0.69%	-	4.96%	0.75%	0.35%	0.4%	0.89%	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	4.49M	35.71M	35.87M	-285K	47.36M	4.83M	8.2M	-3K	20.04M	954K	-1.63M	-2.24M	-992K	-1.69M	-21K	-22K	-21K	-5K	115.83M	301K
Debt Issued (Net)	0	0	0	0	0	0	3.38M	-7K	-21K	-3.35M	-1.69M	-2.24M	-1.13M	-1.69M	-21K	-22K	-21K	-21K	953K	-688K
Equity Issued (Net)	4.49M	37.26M	35.87M	-285K	47.32M	4.83M	1K	4K	2.52M	4.31M	54K	8K	0	0	0	0	0	0	115.62M	989K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	-1.55M	0	0	44K	5K	4.82M	0	17.55M	0	0	0	140K	0	0	0	0	16K	-750K	0
Net Change in Cash	-14.29M	12.8M	33.77M	-17.79M	32.48M	33.79M	-5.96M	-13.68M	39.98M	-9.55M	-15.07M	-15.61M	-17.88M	-27.11M	-18.75M	-20.26M	-17.55M	-21.09M	98.29M	-20.53M
Free Cash Flow	-18.78M	-22.9M	-2.09M	-17.5M	-14.88M	28.96M	-14.16M	-13.68M	19.93M	-10.5M	-13.43M	-13.37M	-16.89M	-25.42M	-18.73M	-20.24M	-17.53M	-21.09M	-17.54M	-20.83M
FCF Margin %	-100.48%	-181.05%	-15.29%	-91.76%	-184.04%	988.26%	-821.52%	-604.55%	845.65%	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-26.23%	-179.08%	85.22%	-27.88%	-174.64%	375.72%	-5.48%	-2.33%	218.01%	58.69%	28.32%	33.95%	3.63%	-20.54%	-6.8%	2.84%	14.81%	7.92%	-36.89%	-
FCF per Share	-0.97	-0.14	-0.03	-1.70	-4.02	5.43	-3.07	-3.02	6.35	-5.27	-6.82	-6.80	-8.61	-12.97	-9.57	-10.34	-8.96	-10.79	-12.24	-381.82
FCF Conversion (FCF/Net Income)	2.94x	2.34x	-0.19x	1.07x	0.91x	-2.18x	1.08x	0.98x	-1.43x	0.61x	0.76x	0.80x	0.86x	1.11x	0.81x	1.01x	0.68x	0.98x	0.87x	1.27x
Interest Paid	0	0	0	0	0	0	0	0	0	62K	0	0	123K	209K	175K	140K	121K	119K	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0